No Data
No Data
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
ADMA Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
ADMA Biologics Up Nearly 32%, on Track for Record High Close -- Data Talk
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
ADMA Biologics Price Target Raised to $20.00/Share From $15.00 by Cantor Fitzgerald
ADMA Biologics Is Maintained at Overweight by Cantor Fitzgerald